0001437749-20-005801.txt : 20200320
0001437749-20-005801.hdr.sgml : 20200320
20200320190100
ACCESSION NUMBER: 0001437749-20-005801
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191230
FILED AS OF DATE: 20200320
DATE AS OF CHANGE: 20200320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pearson Robert W.
CENTRAL INDEX KEY: 0001432527
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38244
FILM NUMBER: 20733254
MAIL ADDRESS:
STREET 1: 3001 MEANDERING RIVER COURT
CITY: AUSTIN
STATE: TX
ZIP: 78746
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Genprex, Inc.
CENTRAL INDEX KEY: 0001595248
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900772347
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1601 TRINITY STREET, BLDG. B
STREET 2: SUITE 3.322
CITY: AUSTIN
STATE: TX
ZIP: 78712
BUSINESS PHONE: 512-537-7997
MAIL ADDRESS:
STREET 1: 1601 TRINITY STREET, BLDG. B
STREET 2: SUITE 3.322
CITY: AUSTIN
STATE: TX
ZIP: 78712
4/A
1
rdgdoc.xml
FORM 4/A
X0306
4/A
2019-12-30
2020-01-02
0001595248
Genprex, Inc.
GNPX
0001432527
Pearson Robert W.
1601 TRINITY STREET
BLDG B, STE 3.322
AUSTIN
TX
78712
1
Stock Option (Right to Buy)
1.45
2019-12-30
4
A
0
68376
0
A
2020-06-10
2029-12-30
Common Stock
68376
68376
D
Equal to the fair market value of a share of common stock on June 10, 2019, the date on which the option grant was to be made under the Genprex, Inc. Outside Director Compensation Policy.
One hundred percent (100%) of the Shares subject to the Option shall vest upon the earlier of (a) the one (1) year anniversary of June 10, 2019 and (b) the day prior to the Company's next annual meeting of the Company's stockholders occurring after the grant date, provided that the Optionee continues to serve as a Service Provider (as defined in the Genprex, Inc. 2018 Equity Incentive Plan) through the applicable vesting date.
This Form 4 amendment is being filed to reflect that on March 18, 2020, the Option was amended to provide that one hundred percent (100%) of the Shares subject to the Option became exercisable on March 18, 2020.
/s/ Robert W. Pearson
2020-03-20